Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01348451
Recruitment Status : Unknown
Verified March 2016 by Neuralstem Inc..
Recruitment status was:  Active, not recruiting
First Posted : May 5, 2011
Last Update Posted : March 10, 2016
Sponsor:
Information provided by (Responsible Party):
Neuralstem Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : December 2015
Estimated Study Completion Date : December 2016
Publications of Results:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):